Li Y - Search Results

1

Sutureless laparoscopic heminephrectomy using laser tissue soldering.

Ogan K, Jacomides L, Saboorian H, Koeneman K, Li Y, Napper C, Hoopman J, Pearle MS, Cadeddu JA. Ogan K, et al. Among authors: li y. J Endourol. 2003 Jun;17(5):295-300. doi: 10.1089/089277903322145468. J Endourol. 2003. PMID: 12885354

2

Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase.

Cui W, Otten P, Li Y, Koeneman KS, Yu J, Mason RP. Cui W, et al. Among authors: li y. Magn Reson Med. 2004 Mar;51(3):616-20. doi: 10.1002/mrm.10719. Magn Reson Med. 2004. PMID: 15004806 Free article.

3

Synthesis and evaluation of a novel gene reporter molecule: detection of beta-galactosidase activity using 19F NMR of a fluorinated vitamin B6 conjugate+.

Yu J, Ma Z, Li Y, Koeneman KS, Liu L, Mason RP. Yu J, et al. Among authors: li y. Med Chem. 2005 May;1(3):255-62. doi: 10.2174/1573406053765495. Med Chem. 2005. PMID: 16787321

4

Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.

Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS. Melquist JJ, et al. Among authors: li y. Urol Oncol. 2006 Jul-Aug;24(4):362-71. doi: 10.1016/j.urolonc.2005.11.028. Urol Oncol. 2006. PMID: 16818192

5

Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model.

Canales BK, Li Y, Thompson MG, Gleason JM, Chen Z, Malaeb B, Corey DR, Herbert BS, Shay JW, Koeneman KS. Canales BK, et al. Among authors: li y. Urol Oncol. 2006 Mar-Apr;24(2):141-51. doi: 10.1016/j.urolonc.2005.11.003. Urol Oncol. 2006. PMID: 16520278

6

Osteoblasts can stimulate prostate cancer growth and transcriptionally down-regulate PSA expression in cell line models.

Li Y, Sikes RA, Malaeb BS, Yeung F, Law A, Graham SE, Pei M, Kao C, Nelson J, Koeneman KS, Chung LW. Li Y, et al. Urol Oncol. 2011 Nov-Dec;29(6):802-8. doi: 10.1016/j.urolonc.2009.09.016. Epub 2010 May 6. Urol Oncol. 2011. PMID: 20451417

7

Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer.

Li Y, Kacka M, Thompson M, Hsieh JT, Koeneman KS. Li Y, et al. Urol Oncol. 2011 Nov-Dec;29(6):624-33. doi: 10.1016/j.urolonc.2009.08.012. Epub 2009 Dec 6. Urol Oncol. 2011. PMID: 19963408

8

Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.

Li Y, Malaeb BS, Li ZZ, Thompson MG, Chen Z, Corey DR, Hsieh JT, Shay JW, Koeneman KS. Li Y, et al. Among authors: li zz. Prostate. 2010 May 1;70(6):616-29. doi: 10.1002/pros.21096. Prostate. 2010. PMID: 20043297 Free PMC article.

9

The role of cell adhesion molecule in cancer progression and its application in cancer therapy.

Okegawa T, Pong RC, Li Y, Hsieh JT. Okegawa T, et al. Among authors: li y. Acta Biochim Pol. 2004;51(2):445-57. Acta Biochim Pol. 2004. PMID: 15218541 Review.

10

Cell adhesion proteins as tumor suppressors.

Okegawa T, Li Y, Pong RC, Hsieh JT. Okegawa T, et al. Among authors: li y. J Urol. 2002 Apr;167(4):1836-43. J Urol. 2002. PMID: 11912444 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,017 results

Search Page

Filters